Lv32
310 积分 2024-01-31 加入
Ezetimibe: Integrating Established Use with New Evidence - A Comprehensive Review
6小时前
已完结
Reducing LDL-Cholesterol to Very Low Levels: Sailing Between Established Benefits and Potential Risks
8小时前
求助中
Medium-intensity statin with ezetimibe versus high-intensity statin in acute ischemic cerebrovascular disease (MESIA): A randomized clinical trial
1天前
已完结
Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review
21天前
已完结
Strike early–strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registry
24天前
已完结
Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab
24天前
已完结
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
24天前
已完结
Early Versus Delayed Antihypertensive Treatment After Acute Ischemic Stroke by Hypertension History
26天前
已完结
Coronary Atherosclerotic Plaque Activity and Risk of Myocardial Infarction
1个月前
已完结
Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial
1个月前
已完结
皖公网安备34019202002308
